are potent inducers of the unfolded protein response (UPR), a cellular mechanism evolved to cope with protein-folding stress. [11] [12] [13] [14] Indeed, accumulating evidence has shown that the UPR is activated in the myocardium by I/R. [15] [16] [17] [18] [19] The UPR comprises 3 discrete signaling branches: PERK, IRE1/Xbp1s (spliced X-box binding protein 1), and ATF6. These signaling cascades are maintained at quiescent, basal levels by GRP78 (78 kDa glucose-regulated protein), a master endoplasmic reticulum (ER)-resident protein chaperone. 20 GRP78 interacts with the luminal domains of these 3 transmembrane molecules and retains them on the ER membrane surface. However, when misfolded proteins accumulate, GRP78 preferentially interacts with hydrophobic patches on the ER-resident misfolded proteins, thereby releasing the 3 signaling arms of the UPR. Activation of the UPR leads to transient suppression of protein translation, elevation of ER protein-folding chaperones, and upregulation of ER-associated protein degradation. However, if the protein-folding stress is severe or persistent, apoptotic cell death is triggered for the benefit of the whole organism.
Our earlier studies have demonstrated that activation of the IRE1/Xbp1s pathway in I/R is cardioprotective in part through the activation of the hexosamine biosynthetic pathway and resulting increases in O-GlcNAc (O-linked β-Nacetylglucosamine) protein modification. 21 Whether other downstream targets of Xbp1s also participate in myocardial protection from I/R damage is unknown. Here, we set out to investigate whether and how cardiomyocyte GRP78, an Xbp1s target, is protective of I/R stress.
Methods
The data, methods, and study materials are available on request by contacting the corresponding authors. An expanded Methods section is provided in the Online Data Supplement.
Animals
All mice were of C57BL/6 background. They were maintained on a 12-hour dark/light cycle (6 am to 6 pm) and housed in groups of ≤5 with unlimited access to water and chow (2916, Teklad). The Institutional Animal Care and the Use Committee of University of Texas Southwestern Medical Center approved all animal experiments. All polymerase chain reaction primers are provided in Online Table I .
Results

I/R Injury Induces GRP78
We have shown previously that I/R injury to the myocardium is a potent inducer of the UPR. 22 Xbp1s, the most highly conserved branch of the UPR is strongly augmented. 22 As GRP78 is a bona fide target of Xbp1s, 15, 21, [23] [24] [25] [26] we set out to determine whether GRP78 is stimulated in I/R-stressed cardiomyocytes.
To do this, we subjected neonatal rat ventricular myocytes (NRVM) to simulated I/R (sI/R) by replacing the culture medium with Esumi ischemic buffer and incubating the cells in a 95% N 2 /5% CO 2 hypoxia chamber (Online Figure IA) . 27, 28 After 3 to 6 hours, the normal culture medium was restored. First, we confirmed that sI/R elicited time-dependent cell death as assessed by lactate dehydrogenase release ( Figure 1A ). To determine the mode of cell death, we performed annexin V-FITC and propidium iodide double staining followed by flow cytometry (Online Figure IB) . Consistent with the lactate dehydrogenase release findings, sI/R triggered a significant increase in cell death, which was mainly accounted for by annexin V-positive apoptotic cells ( Figure 1B) . By contrast, the pool of cells harboring markers of necrosis was not affected by sI/R. Simulated I/R led to robust induction of GRP78 at both mRNA and protein levels ( Figure 1C and 1D) , consistent with previous findings. 29 Expression of GRP94, another ERresident chaperone, was also strongly increased. These results confirm that sI/R in cardiomyocytes leads to potent activation 
Novelty and Significance
What Is Known?
• Coronary reperfusion after ischemia/reperfusion (I/R) triggers a second wave of injury to the heart. • GRP78 (78 kDa glucose-regulated protein) is strongly induced by I/R in the heart.
What New Information Does This Article Contribute?
• Cardiomyocyte-specific overexpression of GRP78 confers cardioprotection against I/R damage.
• When activated, GRP78 translocates to the cardiomyocyte cell surface membrane, stimulates prosurvival Akt signaling, and diminishes the accumulation of reactive oxygen species.
Myocardial infarction is a leading cause of death worldwide.
Restoration of blood flow in the infarct-related artery is a major approach to mitigate cardiac damage and improve clinical outcomes. Reperfusion per se, however, triggers additional injury. Indeed, reperfusion injury may account for up to 40% of final infarct size. GRP78, a master endoplasmic reticulum-resident chaperone, is potently induced by I/R in the heart. In this study, we show that overexpression of GRP78 in cardiac myocytes strongly protects the heart against I/R injury. At a mechanistic level, GRP78 migrates to the cell surface membrane, directly stimulates the Akt pathway and ameliorates the production of reactive oxygen species. These findings uncover a previously unrecognized role of GRP78 in protecting cardiomyocytes against I/R injury, thereby highlighting a novel pathway with potential therapeutic relevance.
of the UPR, as evidenced by induction of the ER chaperones GRP78 and GRP94.
Overexpression of GRP78 Protects Cardiomyocytes From I/R-Induced Cell Death
To define the downstream effects of I/R-triggered expression of GRP78, we initially pursued a gain-of-function approach. First, we overexpressed GRP78 in NRVM by adenoviral infection 30 ( Figure 2A ) and then subjected the cells to sI/R. Under these conditions, overexpression of GRP78 induced modest but reproducible and statistically significant decreases in cell death as assayed by lactate dehydrogenase release ( Figure 2B ). Additionally, flow cytometry analysis corroborated that GRP78 overexpression protected NRVM from sI/R-induced cell death, which was largely a result of the decreased abundance of annexin V-positive apoptotic cells ( Figure 2C and 2D) . Together, these in vitro results demonstrate that GRP78 overexpression is sufficient to protect cardiomyocytes from I/R injury and suggest that a component of the protection afforded by UPR induction during I/R derives from increases in GRP78.
To test more directly the cardioprotective role of GRP78 in I/R injury, we turned to an in vivo mouse model. We engineered mice with cardiomyocyte-specific overexpression of GRP78. To do this, we generated a transgenic mouse model in which GRP78 is expressed under the control of a universal CAG (CMV, β-actin, and β-globin) promoter ( Figure 3A) . A floxed transcriptional/translational stop cassette 31 was inserted between the CAG promoter and GRP78 cDNA, and the animals were crossed with mice harboring a cardiomyocyte-specific Cre recombinase transgene (αMHC-Cre [alpha-myosin heavy chain promoter-driven Cre recombinase]). First, we confirmed in the double transgenic mice that Cre-mediated excision of the stop region triggered expression of GRP78 in cardiomyocytes ( Figure 3B ). Prior studies have shown that overexpression in liver of GRP78, a master regulator of the UPR, leads to decreases in UPR downstream targets, such as Xbp1s. 32 Consistent with this, we found that overexpression of GRP78 induced a trend toward decreases in the level of transcripts coding for multiple UPR markers (Online Figure IIA) , but significant differences were not seen in UPR marker proteins (Online Figure IIB) . Furthermore, control and transgenic mice manifested similar body weight (Online Figure IIC) , heart rate (Online Figure IID) , ventricular size and contractile function (Online Figure IIE) , and myocardial tissue histology (Online Figure IIF) at baseline. Double transgenic, GRP78-expressing mice 12 to 14 weeks of age were subjected to 45 minutes of myocardial ischemia followed by reperfusion for 24 hours. Single transgenic mice (either αMHC-Cre or CAG-STOP-GRP78) were used throughout as controls. Histological staining with 2,3,5-triphenyltetrazolium chloride revealed that cardiomyocyte overexpression of GRP78 significantly protected heart from I/R damage as compared with single transgene controls . A, Simulated I/R (sI/R) elicited significant cell death. Neonatal rat ventricular myocytes (NRVM) were treated for either 3 h or 6 h of ischemia before reperfusion. Lactate dehydrogenase (LDH) was determined in culture medium and in cell lysates. Relative cell death was calculated based on the ratio of released LDH into the medium. N=6 per group. B, Cell death by sI/R was determined using flow cytometry to detect annexin V-and propidium iodide (PI)-positive cells. Significant increases in annexin V-positive apoptotic cells were observed, which accounted for the preponderance of cell death. N=3 for each group. C, sI/R led to strong induction of endoplasmic reticulum (ER) resident chaperones at mRNA levels. NRVM were subjected to ischemia for 6 h, followed by overnight reperfusion. Real-time polymerase chain reaction was conducted to measure mRNA levels with 18S as an internal control. N=3 per group. D, sI/R induced expression of the ER chaperones at protein levels. Immunoblotting showed that GRP78 and GRP94 were significantly increased at protein levels (left). GAPDH was used as a loading control. Quantification is shown at right. N=3. NS indicates not significant. *P<0.05. ***P<0.001. May 25, 2018
( Figure 3C ). Quantitative analysis of the 2,3,5-triphenyltetrazolium chloride staining revealed a significant decrease in the volume of the infarct, even though the extent of ischemic insult was similar, as evidenced by similar areas at risk ( Figure 3D ). Consistent with less infarction in the double transgenic hearts, I/R-elicited fibrosis was reduced by GRP78 overexpression ( Figure 3E ). Taken together, these findings of robust protection against I/R injury elicited by GRP78 overexpression under both in vitro and in vivo conditions suggest that important aspects of UPR-Xbp1s-driven cardioprotection are mediated by GRP78.
GRP78 Blunts Accumulation of ROS
Accumulation of ROS is a central mechanism of I/R injury in the heart. [33] [34] [35] Oxygen free radicals and other reactive species modify proteins by posttranslational modifications, including carbonylation. This event is a prevalent posttranslational modification occurring on lysine, proline, or threonine residues and culminating in effects on target protein localization, stability, and function. 36 To determine whether GRP78 expression modulates ROS production, we first assayed protein carbonyl modifications. We infected NRVM with either control or GRP78 adenovirus and then subjected the cells to sI/R. After protein isolation, the lysates were incubated with DNP (2,4-dinitrophenylhydrazine), which is covalently conjugated to carbonyl groups, followed by immunoblotting using DNP-specific antibodies. As expected, sI/R in NRVM strongly induced protein carbonylation ( Figure 4A and 4B). Furthermore, overexpression of GRP78 significantly ameliorated this modification, suggesting that GRP78 expression in NRVM suppresses ROS toxicity. Whereas cardiomyocyte-specific overexpression of GRP78 did not alter carbonylation levels at baseline (Online Figure   IIG) , tissue lysates from control animals subjected to I/R manifested robust protein carbonylation, which was significantly reduced in GRP78 cardiomyocyte-specific transgenic mice (Figure 4A and 4B; Online Figure IIH) .
To confirm that the increase in protein carbonylation was indicative of increased ROS levels, we quantified those levels using dihydroethidium, a dye that emits blue fluorescence in the cytosol and which stains the nucleus red when oxidized. Using flow cytometry, we observed that sI/R elicited a significant increase in the mean red fluorescence signal which was reduced by GRP78 overexpression ( Figure 4C ).
Multiple intracellular pathways contribute to the production of ROS, and we set out to dissect the sources of ROS regulated by GRP78. Diphenyleneiodonium and MitoTEMPO were used to suppress ROS production by NADPH oxidase and mitochondria, respectively. The increases in dihydroethidium fluorescence triggered by sI/R were significantly reduced individually by diphenyleneiodonium, by MitoTEMPO, and by GRP78 overexpression (Online Figure II-I) . In contrast to MitoTEMPO, however, the combination of GRP78 adenovirus and diphenyleneiodonium did not yield an additive effect, suggesting that ROS regulation by GRP78 is largely mediated by NADPH oxidase (Online Figure II-I) . In aggregate, these data indicate that I/R potently induces cardiomyocyte ROS levels and consequent protein oxidation, both of which are diminished by GRP78 overexpression.
GRP78 Expression Stimulates Akt Signaling
Akt, also named protein kinase B, is a signaling nexus governing cell survival, cell proliferation, and cell growth, 37 and is potently activated by I/R. 38 Numerous studies have shown that Akt plays pivotal roles in protecting cardiac myocytes from I/R injury. [38] [39] [40] To test whether Akt participates in the cardioprotective effects of GRP78, we first examined the relationship between increased GRP78 levels and Akt activation. Under basal conditions, overexpression of GRP78 in NRVM did not significantly alter the activation of Akt as determined indirectly by Akt phosphorylation at both Thr 308 and Ser 473 residues ( Figure 5A and 5B). As expected, 6 hours of ischemia followed by 1 hour of reperfusion, however, stimulated Akt phosphorylation. Importantly, overexpression of GRP78 in the context of sI/R triggered yet further, statistically significant Akt activation ( Figure 5A and 5B). Phosphorylation of Erk, on the other hand, showed no significant changes as a result of GRP78 overexpression. We have shown previously that augmentation of protein O-GlcNAcylation in the heart confers strong cardioprotection in response to I/R. 16, 22 Here, no significant changes in O-GlcNAcylation were revealed by GRP78 overexpression (Online Figure IIIA) , indicating that this posttranslational modification may not participate in GRP78-mediated protection against reperfusion injury.
Similarly, overexpression of GRP78 in vivo was sufficient to activate Akt in GRP78-expressing transgenic hearts ( Figure 5C and 5D) . Again, no changes in Erk phosphorylation were observed. In aggregate, these data suggest that GRP78 overexpression leads to activation of Akt signaling in cardiomyocytes.
To unveil mechanisms whereby GRP78 stimulates Akt, we examined cell surface localization of GRP78. Previous studies in tumor cells have shown that GRP78 translocates to the cell surface membrane under stress conditions, and this specific localization promotes Akt stimulation. 25, 41 To test for this in cardiomyocytes, we isolated cell membranes from cardiac tissues after I/R and subjected them to sucrose gradient fractionation. We found that the plasma membrane could be readily separated from SR/ER membrane. More importantly, GRP78 was detected in the same fractions as plasma membrane (Online Figure IIIB) .
To evaluate GRP78 cell surface localization further, we subjected NRVM to sI/R, followed by crosslinking with EZlink Sulfo-NHS-LC-Biotin. After isolation of biotinylated surface proteins, immunoblotting was conducted to reveal GRP78. 42 We found that GRP78 was localized to the cardiomyocyte surface under normoxic conditions, and this cell surface localization was significantly increased after sI/R (Online Figure IIIC) .
Recent studies suggest that cell surface-localized GRP78 interacts with PI3K and activates its kinase activity, thereby generating PIP3 (phosphatidyl inositol (3,4,5)-triphosphate) and stimulating Akt. 43 Consistent with this, we observed that Flag-tagged GRP78 colocalized with p85, the regulatory subunit of PI3K (Online Figure IVA and IVB) . Zhang et al 43 have shown that an insertion mutant of GRP78 remains capable of cell surface translocation but binding with PI3K is disrupted. To evaluate this mechanism in NRVM, we engineered the insertion mutant species and compared its PI3K binding with that of wild-type GRP78. We found that colocalization of the mutant GRP78 with p85 was significantly diminished (Online Figure IVA and IVB) , which correlated with impaired production of PIP3 (Online Figure IVC and  IVD) . Indeed, the biotinylation assay demonstrated that Area at risk (%LV) * NS A Figure 3 . Overexpression of GRP78 (78 kDa glucose-regulated protein) protects the heart from ischemia/reperfusion (I/R) injury. A, Strategy of cardiomyocyte-restricted overexpression of GRP78. A mouse model harboring a CAG-loxP-STOP-loxP-GRP78 transgene was engineered and bred to a cardiomyocyte-specific Cre mouse line. In the double transgenic mouse, Cre recombines and cleaves the STOP region, which leads to GRP78 expression exclusively in cardiomyocytes. B, GRP78 expression is increased in the transgenic (TG) hearts. Protein lysates were extracted in control or GRP78-expressing TG hearts and Western blotting was performed to detect GRP78 protein levels. GAPDH was used as a loading control. C, Overexpression of GRP78 in cardiomyocytes protected hearts from I/R damage. Control and TG mice 12 to 14 wk of age were subjected to myocardial ischemia for 45 min, followed by overnight reperfusion. 2,3,5-triphenyltetrazolium chloride staining was conducted to detect, localize, and quantify the injured tissue. White region depicts ischemic infarct zone; pink/red area is the border zone; blue region represents the remote zone. Scale bar: 1 mm. D, The relative ratios of infarct region (IF) to the area at risk (AAR, ischemic and border) were compared between control and TG hearts. The relative ratios of AAR to left ventricle did not differ between control and TG groups, suggesting the I/R surgery was performed similarly across genotypes. N=5 per group. E, TG mice manifested a decrease in fibrosis after I/R. Hearts from control and TG mice were harvested 21 d after I/R. Trichrome staining was conducted to compare fibrosis between the 2 groups. Scale bar: 100 μm. NS indicates not significant. *P<0.05. May 25, 2018 overexpression of wild-type GRP78 stimulated cell membrane association of p85 that was significantly decreased when mutant GRP78 was expressed (Online Figure IVE) . To further evaluate for direct interaction between membrane GRP78 and p85, we eluted biotinylated cell membrane proteins and immunoprecipitated GRP78. We found the associated p85 was reduced in cells overexpressing mutant GRP78 (Online Figure IVF) . We next sought to determine the functional effects of wild-type and mutant GRP78. Overexpression of GRP78 protected NRVM from sI/R-induced cell death as evidenced by lactate dehydrogenase release assay, whereas mutant GRP78 was less protective (Online Figure VA through VC) . At the cellular level, we found that the antiapoptotic actions of GRP78 were significantly attenuated with the mutant (Online Figure VD and VE), correlating with less suppression of ROS accumulation (Online Figure VF) . Collectively, these results indicate that GRP78, when upregulated, translocates to the cardiomyocyte plasma membrane, where it interacts with PI3K and stimulates Akt.
Akt Signaling Is Required for GRP78-Mediated Cardioprotection Against I/R
To determine whether GRP78-mediated Akt activation participates in the cardioprotective effects we have observed, we used 2 structurally distinct small molecule inhibitors of Akt. LY294002 is a PI3K inhibitor commonly used to suppress the PI3K/Akt pathway. 44 As expected, treatment of NRVM with LY294002 inhibited Akt phosphorylation in a dose-dependent manner ( Figure 6A, left) . Likewise, Akt inhibitor VIII, a cellpermeable inhibitor of Akt, 45 suppressed Akt phosphorylation in a dose-dependent manner ( Figure 6A, right) . We then utilized these tools to test the necessity of Akt activation in GRP78-mediated I/R cardioprotection. We treated NRVM (24 hours) expressing GRP78 with either LY294002 (10 μmol/L) or Akt inhibitor VIII (20 μmol/L). After sI/R, we collected both culture medium and cells to measure cell death, finding that GRP78-mediated protection from sI/R-induced cell death was abolished by either Akt repressor ( Figure 6B ). Additionally, measurements of dihydroethidium red fluorescence showed that Akt inhibition blunted GRP78-mediated protection against ROS accumulation ( Figure 6C ). Together, these results suggest strongly that GRP78 expression activates Akt which is, in turn, required for GRP78-mediated protection against I/R injury in cardiomyocytes.
Discussion
Multiple lines of evidence point to critical roles of UPR activation in ischemic heart disease, including the major signaling Figure 4 . Overexpression of GRP78 (78 kDa glucose-regulated protein) ameliorates reactive oxygen species (ROS) production by ischemia/reperfusion (I/R). A, Overexpression of GRP78 in vitro and in vivo led to decreases in I/R-induced ROS levels. Protein lysates from neonatal rat ventricular myocytes (NRVM) or cardiac tissues were incubated with dinitrophenylhydrazine, which interacts with carbonyl groups in proteins. Immunoblotting was then conducted to detect carbonylation using anti-DNP antibodies. Simulated I/R (sI/R) increased carbonyl modifications in NRVM, which was significantly reduced by GRP78 overexpression. Likewise, overexpression of GRP78 in heart suppressed I/R-induced protein carbonylation. B, Quantification of data depicted in A revealed significant decreases in protein carbonylation triggered by GRP78 expression in NRVM or hearts. N=4 per group. C, Flow cytometry for dihydroethidium, a superoxide indicator, showed that overexpression of GRP78 led to a strong reduction of I/R-elicited ROS levels. N=3 for each group. *P<0.05. **P<0.01. ***P<0.001.
cascades of ATF6 29,46-48 and IRE1/Xbp1s. 22, 49 However, whereas UPR activation in I/R injury is cardioprotective, 7, 15, 17 underlying mechanisms remain poorly characterized. Here, we confirm that I/R injury triggers robust increases in the expression of GRP78. 48, 49 We go on to demonstrate that overexpression of GRP78, both in vitro and in vivo, protects myocytes from I/R-induced cell death. Exploration of underlying mechanisms revealed that GRP78 mitigates cellular damage, and ultimate apoptosis, by its cell surface translocation, interaction with PI3K, activation of Akt, and suppression of ROS accumulation. Finally, our findings point to a necessary role for GRP78-dependent activation of Akt, independent of GRP78-mediated protein chaperone activity, in the antioxidant and cardioprotective responses.
UPR Activation in Ischemic Heart Disease
Activation of the UPR in cardiomyocytes has been reported previously, 15 and evidence points to meaningful cardioprotective effects in the setting of disease-related stress. 17 Those cardioprotective effects have been assigned to both the ATF6 arm of the UPR, 29, [46] [47] [48] as well as to the IRE1/Xbp1s arm. 22, 49 Protein O-GlcNAcylation is cardioprotective, [50] [51] [52] [53] [54] [55] and we have reported that Xbp1s-dependent activation of the hexosamine biosynthetic pathway drives this response. 23 However, whether other UPR effectors participate in the cardioprotective response, and if so by what mechanisms, remains unknown. Some evidence points to GRP78, a molecule which functions as both UPR governor and UPR target, in this biology. Martindale et al 48 and Thuerauf et al 49 have reported that myocardial ischemia stimulates GRP78 expression. Furthermore, inducible overexpression in cardiomyocytes of the ATF6 arm of the UPR confers cardioprotection against I/R, which is associated with strong induction of GRP78. 46, 48 In fact, evidence suggests that GRP78 is upregulated by both hypoxic insult and by reoxygenation. 23 As noted, we have shown previously that induction of the Xbp1s branch of the UPR also confers protection to the heart in response to I/R, a pathway which also upregulates GRP78. 22 In fact, ATF6 and Xbp1s are known to form a heterodimer that activates GRP78 transcription. 26, 56 Despite these findings, the role of GRP78 per se in I/R has not been elucidated, and its downstream effectors have remained obscure.
GRP78
GRP78 is a direct transcriptional target of the UPR-induced transcription factors Xbp1s and ATF6. 15, 21, [23] [24] [25] [26] Expression of GRP78, which is itself an ER chaperone, augments proteinfolding capacity of the ER, helps translocate aberrant protein out of the ER for degradation and can also act ultimately to shut down the UPR branches. 26 Prior studies have shown that GRP78 is strongly induced by I/R at both mRNA and protein levels. 22, 29, 48, 49 Moreover, overexpression of either Xbp1s or ATF6 in cardiomyocytes leads to increases in GRP78. 22, 46, 48 Even brief stimulation by tunicamycin, an ER stress inducer, enhances GRP78 expression, which is associated with protection against subsequent I/R damage. 57 Of note, most of these studies attribute GRP78-related cardioprotection to enhanced protein folding capacity within the ER. A direct role for GRP78 in protection against I/R injury has never yet been demonstrated.
GRP78 orchestrates the action of the 3 distinct branches of the UPR in an integrated manner to maintain cellular homeostasis. 20, 58, 59 Indeed, silencing of GRP78 leads to widespread ER stress that is unresolvable and culminates in cell death. 60 GRP78 acts not only to govern activation of the UPR as a sensor of protein-folding stress, it also functions as a chaperone that enhances ER protein folding capacity and facilitates disposal of unfolded protein by means of ERassociated degradation 61 ; this protein chaperone activity likely plays some role in the cardioprotection we observe. Fu et al 62 have shown that overexpression of GRP78 protects cardiac myocytes from proteasome inhibition-induced cell death. In addition, GRP78 may confer beneficial effects in reperfusion by reducing proapoptotic signaling of the UPR. 17, 63, 64 Consistent with this, chemical chaperone treatment leads to significant protection against I/R injury. 65, 66 Outside the ER, GRP78 has been shown to have a host of roles, from suppression of apoptotic signals to regulation of mitochondrial energy balance. 25 GRP78 has also been reported to promote cell survival by the Akt and NF-κB signaling cascades. 67 Data reported here in the context of cardiac I/R injury reveal that GRP78 mediates activation of the Akt pathway and inhibition of oxidative stress, which occurs in addition to its chaperone function. 29, 48 Collectively, our results uncover a novel mechanism linking UPR activation, Akt signaling, and oxidative stress in I/R.
Oxidative Stress in Myocardial I/R Injury
I/R stress to the heart involves a phase of oxygen and nutrient deprivation followed by abrupt restoration of blood flow in the previously occluded artery; both phases elicit a wide range of molecular events in cardiac myocytes. 5 During hypoxic conditions, cardiomyocytes respond with alterations in metabolic pathways, intracellular signaling, and functionality. 4 Metabolically, oxidation of nutrients is severely suppressed because of the lack of oxygen. 68 As a consequence, glycolysis, occurring in the absence of oxygen consumption, becomes the predominant means of energy production. To accommodate these dramatic changes in metabolic events, the cellular metabolic machinery adjusts accordingly.
During reperfusion, the sudden influx of nutrients, such as free fatty acids and glucose, as well as restoration of oxygen, together replenish components necessary for oxidative phosphorylation and more efficient ATP production. However, ischemia-induced changes to the electron transport chain result in increases in the mitochondrial generation of ROS. 4 Indeed, overproduction and accumulation of ROS or other free radicals play a central role in I/R injury to the heart. 35, 69 Suppression of ROS by genetic or pharmacological approaches strongly protects the heart from I/R damage. 62 We report that GRP78 inhibits ROS accumulation through activation of Akt. Interestingly, GRP78's function as an ERresident chaperone seems at first difficult to reconcile with a role in Akt activation and ROS regulation. However, recent studies from the cancer field provide pertinent clues. 41 GRP78 can translocate to the cell surface under certain conditions. 25, 42, 70 This translocation within tumor cells is critical to GRP78-dependent protection against several stressors.
65
Here, we tested this in NRVM; under conditions of sI/R or adenovirus-mediated overexpression of GRP78, we find that, indeed, a fraction of GRP78 is translocated to the cell surface, and we demonstrate that this leads to GRP78 interaction with PI3K and consequent Akt activation. Our results also suggest that some GRP78 may be localized at the cell surface even under normoxic conditions, and on induction by I/R, cell membrane translocation is significantly increased. These data are consistent with reports that an anti-GRP78 monoclonal antibody inhibits signaling mediated by cell surface-localized GRP78 and thereby suppresses downstream PI3K/Akt signaling to block tumor growth and metastasis. 71 Other studies have shown that GRP78 itself is a suppressor of apoptosis by interacting with caspase 7 72 or Bcl-2. 73 In addition, GRP78 is also associated with Raf-1 in mitochondria, protecting cells from ER stress-induced apoptosis. 74 Thus, GRP78 may protect cardiomyocytes from I/R injury via multiple mechanisms, and the relative importance of each warrants further investigation. B, Suppression of Akt signaling abolished GRP78-mediated protection against ischemia/reperfusion (I/R) damage. Control or GRP78 adenovirus was used to infect NRVM for 48 h. Cells were then subjected to simulated I/R (sI/R). Akt inhibitors were incubated during ischemia and reperfusion. Relative cell death was determined by lactate dehydrogenase (LDH) assay. N=4 per group. C, Akt signaling was required for GRP78-mediated suppression of reactive oxygen species (ROS) production. After treatment with Akt inhibitors during sI/R, flow cytometry for dihydroethidium, a superoxide indicator, was conducted to determine relative ROS levels. N=3 for each group. *P<0.05.
Conclusions and Perspectives
It is established that myocardial I/R injury activates the UPR and promotes GRP78 expression. Here, we report that one critical downstream effector of the UPR, GRP78, directly mitigates I/R injury. This beneficial effect stems largely from Akt-dependent inhibition of ROS accumulation. Thus, modulation of GRP78 signaling represents a novel target in myocardial I/R injury and one with potential therapeutic relevance.
